About us
Founder:
Dr. Guannan Wang, founder of VetOmics, brings over a decade of expertise in cancer genomics and precision medicine, and a strong commitment to advancing cancer care for companion animals.
During her time at the University of Pennsylvania and Vidium Animal Health, Dr. Wang played a key role in integrating genomic diagnostics into routine cancer care for dogs. She has led the development of cutting-edge genomic tools and precision oncology databases, and has personally overseen thousands of canine genomic reports.
Dr. Wang has contributed significantly to the field of canine cancer genomics, particularly in understanding the genomic drivers of hemangiosarcoma. She also led research that demonstrated the clinical utility of genomic testing in guiding treatment decisions, aiding-in diagnosis, and improving patient outcomes.
Together with her co-founder and a team of dedicated advisors, Dr. Wang founded VetOmics to deliver high-quality, high-actionability genomic tests, empowering veterinarians to offer the best possible care for pets fighting cancer.

Dr. Ming Wu is an expert in bioinformatics, machine learning, and the computational architecture of genomics data and informatics solutions.
Dr. Barbara E. Kitchell is a leader in veterinary oncology. She is pushing boundaries to expand the veterinary pharmacopeia.
Gary is an entrepreneur and investor who brings over 25 years of digital marketing and startup experience. He is passionate about translating research into impactful commercialization.
Dr. MJ Hamilton is a pioneer in veterinary oncology, known for bringing oncology care directly to general practice through his world-first mobile oncology practice.
Dr. Stephen Shaw is a veterinary oncologist and co-founder of VetPrep and VetTechPrep. He has deep clinical expertise with a passion for education and innovation in veterinary medicine.
Dr. Brenden Boostrom is an oncologist at MedVet. He is passionate about tailoring cancer care to each pet and their family, integrating genomics, and advancing treatments through clinical trials.
